Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Reddit Inc (RDDT) vs Summit Therapeutics Inc (SMMT) Price & Performance

Reddit IncTrade
Summit Therapeutics IncTrade

Price performance (Past 24H)

Key statistics

Reddit Inc vs Summit Therapeutics Inc — how do they compare? Reddit Inc trades at $147.15 (market cap $28.74B), while Summit Therapeutics Inc trades at $17.55 (market cap $13.79B). The key difference: Reddit Inc is far larger — about 2.1× Summit Therapeutics Inc's market cap, and Summit Therapeutics Inc is trading nearer its 52-week high, Reddit Inc nearer its low. Which is the better fit depends on your goals.

RDDTSMMT
Market Cap
$28.74B$13.79B
Sector
MediaHealth
52-Week High
$270.71$26.38
52-Week Low
$121.84$12.43
Enterprise Value
$25.97B$13.11B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Reddit Inc

Reddit (RDDT) trades at $149.38, down 3.29% amid bearish technical signals, though fundamentals remain strong with 61% YoY revenue growth and consistent earnings beats. The stock faces valuation concerns despite robust profitability margins above 30% and positive analyst sentiment with 64% buy ratings. Recent CEO stock sales and AI licensing renewal risks have contributed to recent volatility.

The outlook remains positive with a $216.08 consensus price target suggesting 45% upside potential, driven by AI monetization and international expansion. Key risks include valuation compression, competitive pressures in digital advertising, and the expiration of major AI data licensing agreements in 2027.

Summit Therapeutics Inc

Summit Therapeutics (SMMT) trades at $17.28, down 1.85% on the day, with a bullish technical signal from moving averages but overbought RSI readings. The company reported a net loss of $1.08 billion for 2025, negative ROE of -192.5%, and relies on financing cash flow for liquidity. Recent news highlights positive Phase III trial results for ivonescimab in lung and biliary tract cancers, driving investor optimism ahead of a key FDA decision in November 2026.

The outlook hinges on regulatory approval and commercial success of ivonescimab, with a consensus price target of $25.23 implying 46% upside. Risks include high cash burn, clinical trial uncertainties, and potential dilution from financing activities. Analyst sentiment is bullish (60.9% buy ratings), but the stock remains speculative due to its pre-revenue status and dependence on pipeline milestones.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Reddit Inc

Reddit Inc. operates a vast network of online communities organized around various interests, known as 'subreddits'. Functioning as a hybrid of a social media platform and a discussion forum, the company generates revenue primarily through advertising and premium subscriptions. Reddit is a major hub for user-generated content, trending news, and viral discussions, and it is a key player in the digital advertising and social media landscape.

Read more on RDDT

About Summit Therapeutics Inc

Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.

Read more on SMMT